Morgan Stanley’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-101
| Closed | – | – | 6906 |
|
|
2019
Q3 | $0 | Sell |
101
-734,377
| -100% | – | ﹤0.01% | 6886 |
|
|
2019
Q2 | $639K | Sell |
734,478
-134,049
| -15% | -$117K | ﹤0.01% | 4475 |
|
|
2019
Q1 | $2.02M | Buy |
868,527
+169,798
| +24% | +$394K | ﹤0.01% | 3572 |
|
|
2018
Q4 | $1.62M | Buy |
698,729
+154,300
| +28% | +$358K | ﹤0.01% | 3936 |
|
|
2018
Q3 | $8.07M | Buy |
544,429
+153,014
| +39% | +$2.27M | ﹤0.01% | 2646 |
|
|
2018
Q2 | $5.95M | Buy |
391,415
+107,239
| +38% | +$1.63M | ﹤0.01% | 2952 |
|
|
2018
Q1 | $5.34M | Buy |
284,176
+156,614
| +123% | +$2.94M | ﹤0.01% | 2966 |
|
|
2017
Q4 | $2.32M | Buy |
127,562
+66,050
| +107% | +$1.2M | ﹤0.01% | 3909 |
|
|
2017
Q3 | $1.37M | Buy |
+61,512
| New | +$1.37M | ﹤0.01% | 4210 |
|